COVID-19 ARDS患者右心室受累的超声心动图表型与ICU死亡率的探索性分析
该研究为ECHO-COVID多中心观察性研究的post-hoc探索性分析,纳入ICU中至少接受两次超声心动图检查的COVID-19 ARDS患者281例,共948次超声检查。右心室受累定义为ACP(右室腔扩张伴室间隔矛盾运动)、RVF(右室腔扩张伴体静脉淤血)和RV功能障碍(三尖瓣环收缩期位移≤16 mm)。67%患者至少出现一种右心室受累。所有检查均显示ACP的患者生存时间缩短为无ACP者的0.479倍(P=0.005);RVF呈缩短趋势(0.642倍,P=0.059);RV功能障碍影响不确定(P=0.451)。多状态模型显示患者可在右心室受累状态间转换,末次重症超声检查显示ACP者死亡风险最高(HR 3.25 [2.38-4.45],P<0.001)。
要点
- COVID-19 ARDS机械通气患者右心室受累总体发生率为67%(189/281),其中ACP 37.4%(105/281)、RVF 54.7%(140/256)、RV功能障碍 29%(74/255)。
- 所有检查均显示ACP者生存时间较无ACP者缩短为0.479倍(95%CI 0.284-0.803,P=0.005)。
- RVF与生存时间缩短呈趋势(0.642倍,95%CI 0.405-1.018,P=0.059),RV功能障碍影响不确定(P=0.451)。
- 末次重症超声检查显示ACP者ICU死亡风险最高(HR 3.25 [2.38-4.45],P<0.001)。
- 患者可在右心室受累表型间转换,动态超声评估有助于识别高危患者。
适用人群与场景
- ICU中因COVID-19 ARDS接受机械通气的患者,且至少接受两次超声心动图检查(ECHO-COVID多中心观察性研究人群)。
诊断标准与关键阈值
- 急性肺源性心脏病(ACP):右室腔扩张伴室间隔矛盾运动。
- 右心室衰竭(RVF):右室腔扩张伴体静脉淤血。
- 右心室功能障碍:三尖瓣环收缩期位移≤16 mm。
红旗征与不能漏的情况
- 末次重症超声检查显示ACP提示ICU死亡风险最高(HR 3.25 [2.38-4.45],P<0.001)。
研究设计与关键结果
- 研究类型:多中心ECHO-COVID观察性研究的post-hoc探索性分析,纳入281例患者,共948次超声心动图检查,采用加速失效时间模型和多状态模型分析。
- 右心室受累总发生率67%(189/281):ACP 37.4%(105/281)、RVF 54.7%(140/256)、RV功能障碍 29%(74/255)。
- 所有检查均显示ACP者生存时间缩短为无ACP者的0.479倍(95%CI 0.284-0.803,P=0.005)。
- RVF与生存时间缩短呈趋势:0.642倍(95%CI 0.405-1.018,P=0.059);RV功能障碍对生存时间影响不确定(P=0.451)。
- 多状态分析显示患者可在右心室受累状态间转换,末次重症超声检查显示ACP者死亡风险最高(HR 3.25 [2.38-4.45],P<0.001)。
证据类型、等级与局限
- 证据类型:多中心观察性研究的post-hoc(探索性)分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为不同右心室受累表型可能对应不同ICU死亡率,ACP预后最差,提示对COVID-19 ARDS机械通气患者应动态行重症超声心动图评估右心室表型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Exploratory study to evaluate the association of different phenotypes of right ventricular (RV) involvement and mortality in the intensive care unit (ICU) in patients with acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19).
METHODS: Post-hoc analysis of longitudinal data from the multicenter ECHO-COVID observational study in ICU patients who underwent at least two echocardiography examinations. Echocardiography phenotypes were acute cor pulmonale (ACP, RV cavity dilatation with paradoxical septal motion), RV failure (RVF, RV cavity dilatation and systemic venous congestion), and RV dysfunction (tricuspid annular plane systolic excursion ≤ 16 mm). Accelerated failure time model and multistate model were used for analysis.
RESULTS: Of 281 patients who underwent 948 echocardiography studies during ICU stay, 189 (67%) were found to have at least 1 type of RV involvements during one or several examinations: ACP (105/281, 37.4%), RVF (140/256, 54.7%) and/or RV dysfunction (74/255, 29%). Patients with all examinations displaying ACP had survival time shortened by 0.479 [0.284-0.803] times when compared to patients with all examinations depicting no ACP (P = 0.005). RVF showed a trend towards shortened survival time by a factor of 0.642 [0.405-1.018] (P = 0.059), whereas the impact of RV dysfunction on survival time was inconclusive (P = 0.451). Multistate analysis showed that patients might transit in and out of RV involvement, and those who exhibited ACP in their last critical care echocardiography (CCE) examination had the highest risk of mortality (hazard ratio (HR) 3.25 [2.38-4.45], P < 0.001).
CONCLUSION: RV involvement is prevalent in patients ventilated for COVID-19 ARDS. Different phenotypes of RV involvement might lead to different ICU mortality, with ACP having the worst outcome.
参考来源
- Huang S, Vieillard-Baron A, Evrard B, et al. Echocardiography phenotypes of right ventricular involvement in COVID-19 ARDS patients and ICU mortality: post-hoc (exploratory) analysis of repeated data from the ECHO-COVID study. Intensive Care Med. 2023. PMID: 37436445. doi:10.1007/s00134-023-07147-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。